BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24124110)

  • 21. The Prognostic Significance of Combined Expression of ZAP-70 and CD38 in Chronic Lymphocytic Leukemia.
    Assem M; Abdel Hamid T; Kohla S; Arsanyos S
    J Egypt Natl Canc Inst; 2009 Dec; 21(4):287-97. PubMed ID: 21415865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].
    Wu Y; Xue Y; Chen S; Yao L; Jiang H; Zhang J; Shen J; Pan J; Wang Y; Bai S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):86-91. PubMed ID: 20140876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation?
    Ghergus D; Martin M; Knapp AM; Delmotte F; Joublin-Delavat A; Jung S; Schickel JN; Mendel I; Dupuis A; Drénou B; Ghesquières H; Salles G; Baseggio L; Herbrecht R; Korganow AS; Vallat L; Soulas-Sprauel P; Meffre E; Martin T
    Am J Hematol; 2024 Jan; 99(1):48-56. PubMed ID: 37853951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Igbeta(CD79b) mRNA expression in chronic lymphocytic leukaemia cells correlates with immunoglobulin heavy chain gene mutational status but does not serve as an independent predictor of clinical severity.
    Cajiao I; Sargent R; Elstrom R; Cooke NE; Bagg A; Liebhaber SA
    Am J Hematol; 2007 Aug; 82(8):712-20. PubMed ID: 17315213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations.
    Raponi S; Ilari C; Della Starza I; Cappelli LV; Cafforio L; Piciocchi A; Arena V; Mariglia P; Mauro FR; Gentile M; Cutrona G; Moia R; Favini C; Morabito F; Rossi D; Gaidano G; Guarini A; Del Giudice I; Foà R
    Br J Haematol; 2020 Jun; 189(5):853-859. PubMed ID: 32064595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma.
    Balakrishna J; Basumallik N; Matulonis R; Scott D; Salem D; Jasper G; Wiestner A; Stetler-Stevenson M; Marti G; Sun C; Yuan CM
    Leuk Lymphoma; 2021 Aug; 62(8):1828-1839. PubMed ID: 33734005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma.
    Menter T; Dirnhofer S; Tzankov A
    J Clin Pathol; 2015 Jun; 68(6):473-8. PubMed ID: 25713417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
    Catherwood MA; Matthews C; Niblock R; Dobbin E; Morris TC; Alexander HD
    Eur J Haematol; 2006 Apr; 76(4):294-8. PubMed ID: 16519700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
    Rodríguez-Vicente AE; Díaz MG; Hernández-Rivas JM
    Cancer Genet; 2013 Mar; 206(3):49-62. PubMed ID: 23531595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
    Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
    N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
    Abousamra NK; El-Din MS; Azmy E
    Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5' Rapid amplification of cDNA ends (5'RACE): A simpler method to analyze immunoglobulin genes and discover the value of the light chain in chronic lymphocytic leukemia.
    Lan X; Ruminy P; Bohers E; Rainville V; Viennot M; Viailly PJ; Etancelin P; Tilly H; Mihailescu S; Bouclet F; Leprêtre S; Jardin F
    Leuk Res; 2022 Dec; 123():106952. PubMed ID: 36272389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of ZAP-70 mRNA by real-time PCR is a prognostic factor in chronic lymphocytic leukemia.
    Wang YH; Zou ZJ; Liu L; Zhang LN; Fang C; Zhu DX; Fan L; Li JY; Xu W
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):1011-7. PubMed ID: 22362302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoglobulin gene rearrangements and mutational status in argentinian patients with chronic lymphocytic leukemia.
    Stanganelli C; Travella A; Bezares R; Slavutsky I
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):447-457.e2. PubMed ID: 23665144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status.
    Baumann T; Delgado J; Santacruz R; Martínez-Trillos A; Rozman M; Aymerich M; López C; Costa D; Carrió A; Villamor N; Montserrat E
    Br J Haematol; 2016 Jan; 172(1):48-55. PubMed ID: 26559905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IGHV gene rearrangements as outcome predictors for CLL patients: experience of Ukrainian group.
    Kryachok I; Abramenko I; Bilous N; Chumak A; Martina Z; Filonenko I
    Med Oncol; 2012 Jun; 29(2):1093-101. PubMed ID: 21503826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic usage of V(H) gene mutation status and its surrogate markers and the role of antigen selection in chronic lymphocytic leukemia.
    Tobin G; Rosenquist R
    Med Oncol; 2005; 22(3):217-28. PubMed ID: 16110132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia.
    Shi K; Sun Q; Qiao C; Zhu H; Wang L; Wu J; Wang L; Fu J; Young KH; Fan L; Xia Y; Xu W; Li J
    Cancer Med; 2020 Feb; 9(3):999-1007. PubMed ID: 31849198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
    Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mutational features of immunoglobulin heavy chain variable region gene in patients with chronic lymphocytic leukemia].
    Li YH; Huang XQ; Lin YN; Chen XJ; Chen L; Liu EB; Mi YC; Ru K
    Zhonghua Bing Li Xue Za Zhi; 2022 Nov; 51(11):1135-1140. PubMed ID: 36323543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.